Back to User profile » Dr Nan Sha

Papers published by Dr Nan Sha:


The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population

Sha N, Xu H, Chen T, Tian DW, Xie WQ, Xie LG, Zhang Y, Xing C, Liu XT, Shen ZH, Wu ZL, Hu HL, Wu CL

OncoTargets and Therapy 2016, 9:1175-1179

Published Date: 7 March 2016

Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study

Zhang Y, Xie LG, Chen T, Xie WQ, Wu ZL, Xu H, Xing C, Sha N, Shen ZH, Qie YK, Liu XT, Hu HL, Wu CL

OncoTargets and Therapy 2016, 9:605-611

Published Date: 28 January 2016

Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis

Xie LG, Sun Y, Chen T, Tian DW, Li YJ, Zhang Y, Ding N, Shen ZH, Xu H, Nian XW, Sha N, Han RF, Hu HL, Wu CL

OncoTargets and Therapy 2015, 8:3679-3690

Published Date: 7 December 2015

Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection

Sha N, Xie L, Chen T, Xing C, Liu X, Zhang Y, Shen Z, Xu H, Wu Z, Hu H, Wu C

OncoTargets and Therapy 2015, 8:3401-3406

Published Date: 18 November 2015